In a meta-analysis of 46 RCTs, behavioral interventions modestly improved HbA1c in youth with T1D; family-focused approaches worked best.
News|Articles|October 2, 2025
Q3 2025: A recap of the top headlines and interviews
Fact checked by: Morgan Ebert, Executive Editor
View our Q3 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.
Advertisement
Advertisement
As we move into the fourth quarter of 2025, Q3 brought several treatment regulatory updates and clinical trial results to help better take care of pediatric patients across the globe.
Related to this article
A GBD analysis of 204 countries estimated measles cases in children under 5 rose from 11.1 million in 2019 to 15.6 million in 2023.
Missed the AAP's new pediatric UTI guideline? This easy-to-read FAQ covers the key changes in diagnosis, treatment, imaging, and prevention.
Christina Boull, MD, explains how pediatricians can recognize dermatologic conditions in darker skin tones and address pigment changes and treatment gaps.
Tezepelumab produced histologic remission in up to 68.9% of patients aged 12+ with EoE vs 3.5% with placebo at week 24, sustained to week 52.
Black race was the strongest predictor of T2-high inflammation in 451 children with severe asthma adjusted for social and environmental factors.
Researchers discuss how testosterone changes during early puberty may influence depression and anxiety symptoms in girls and implications for pediatricians.
A Mott Poll of 2,027 parents found 81% say having a baby costs too much; 73% strongly back state paid leave around birth.
Advertisement
Advertisement